Changes in Vaginal, Cervical and Uterine Microflora With Levonorgestrel Intrauterine Device Placement
Vaginal Microflora and Inflammatory Markers Before and After Levonorgestrel Device Insertion
1 other identifier
observational
13
1 country
1
Brief Summary
The goal of this study is to examine changes in the bacterial ecology and inflammatory markers of the female genital tract with levonorgestrel intrauterine device placement. The specific research objectives of this project include:
- 1.Characterization of vaginal, cervical and uterine bacterial species and communities prior to and after LNG IUD placement using bacterial DNA microarray analysis. Samples will be collected up to 1 week before and 2 months after IUD insertion.
- 2.Characterization of vaginal, cervical and uterine inflammatory cytokine milieu prior to and after LNG IUD placement using human RNA microarray analysis. Samples will be analyzed from up to one day before and three weeks after IUD insertion.
- 3.Establish a tissue bank of vaginal, cervical and uterine specimens for future research.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2011
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2011
CompletedFirst Submitted
Initial submission to the registry
August 21, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2011
CompletedFirst Posted
Study publicly available on registry
December 21, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2013
CompletedJanuary 13, 2016
January 1, 2016
11 months
August 21, 2011
January 11, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in vaginal, cervical and uterine bacterial species with levonorgestrel intrauterine device placement
Characterization of vaginal, cervical and uterine bacterial species and communities prior to and after LNG IUD placement using bacterial DNA microarray analysis
1 week prior to IUD insertion to 2 months after IUD insertion
Secondary Outcomes (1)
Inflammatory cytokine changes with levonorgestrel intrauterine device placement
1 day prior to IUD insertion to 3 weeks after IUD insertion
Eligibility Criteria
Caucasian woman aged 18 to 45 seeking intrauterine contraception meeting inclusion criteria.
You may qualify if:
- Not currently pregnant
- No use of hormonal birth control for at least three months prior to enrollment
- Desiring levonorgestrel IUD for birth control
- Greater than 6 months postpartum
- Greater than 6 weeks after miscarriage
- No antibiotic use in the past 6 weeks
You may not qualify if:
- Uterine Abnormalities
- Current use of hormonal contraceptives or use less than 3 months ago
- Unexplained vaginal bleeding
- Irregular menses
- Cervical dysplasia
- Cervical or vaginal infection in the last 6 weeks
- Douching within the week prior to sample collection
- Use of vaginal lubricants within the week prior to sample collection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Utahlead
- Bayercollaborator
Study Sites (1)
University of Utah Hospital
Salt Lake City, Utah, 84132, United States
Related Publications (1)
Jacobson JC, Turok DK, Dermish AI, Nygaard IE, Settles ML. Vaginal microbiome changes with levonorgestrel intrauterine system placement. Contraception. 2014 Aug;90(2):130-5. doi: 10.1016/j.contraception.2014.04.006. Epub 2014 Apr 21.
PMID: 24835828DERIVED
Biospecimen
A total of 648 samples will be collected from 12 participants for bacterial species and human cytokine analysis in 9 collection visits. Specimens will be collected up to one week prior to IUD insertion and two months after IUD insertion. Vaginal and cervical specimens will be collected using FLOQSwabs® (Copan) to maximize bacterial DNA sample collection. Uterine samples will be collected by uterine irrigation with sterile saline using an embryo replacement catheter.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Janet C Jacobson, MD
University of Utah
Study Design
- Study Type
- observational
- Observational Model
- ECOLOGIC OR COMMUNITY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 21, 2011
First Posted
December 21, 2011
Study Start
January 1, 2011
Primary Completion
December 1, 2011
Study Completion
July 1, 2013
Last Updated
January 13, 2016
Record last verified: 2016-01